Use of Postbiotics as an Immunomodulatory of the Immune Response against Brucellosis in Nellore Calves Immunized with S 19 Vaccine

Background: Brucellosis is an important public health disease and a great problem in the cattle production. Objectives: The aim of this study was to evaluate the immunomodulatory efficiency of a commercial postbiotic in Nellore calves immunized with the Brucella abortus S19 vaccine. Methods: We used...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Microbiology Research Journal International 2021-06, p.52-61
Hauptverfasser: Santos, Caroline Paes dos, Herrera, Heitor Miraglia, Campos, João Bosco Vilela, Trindade, Carolina Santos Pereira Cardoso, Silva, Talia Fernandes, Gonçalves, Emilly Rebeca Antunes, Santos, Filipe Martins, Ramos, Carlos Alberto do Nascimento, Llario, Pedro Fernandéz, Taveira, Amanda Alves Rosa, Oliveira, Carina Elisei de
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Brucellosis is an important public health disease and a great problem in the cattle production. Objectives: The aim of this study was to evaluate the immunomodulatory efficiency of a commercial postbiotic in Nellore calves immunized with the Brucella abortus S19 vaccine. Methods: We used 40 calves negative for Brucella spp. organizated into four treatments during 15 days: InRum (Ingulbal Ruminant®); InPro (Ingulbal Protein®); RumPro (Ingulbal Ruminant® and Ingulbal Protein®); and Cont: control. Collections of whole blood and serum samples were performed at the beginning of the administration of postbiotic and at 15, 45, 75 and 105 days after start the experiment. At 15 days, all animals received the mandatory vaccine S19. In order to assess immunological parameters, the means of total white cells counts, total lymphocytes, monocytes and neutrophils, and total IgG antibodies were determined. Results: It found a significative increase (P
ISSN:2456-7043
2456-7043
DOI:10.9734/mrji/2021/v31i430312